Researchers at MD Anderson have developed an AI-based pathology tool that predicts immunotherapy response in rare cancers by analyzing immune cell changes in biopsies, according to a Journal for ImmunoTherapy of Cancer study.
Clarapath has released an updated FDA-registered SectionStar robotic microtomy system, developed with histotechnologists to enhance efficiency and consistency in clinical histology labs amid staffing and case volume challenges.
PathAI has launched new AI-powered tools on its AISight Clinical Trials Platform, providing standardized histopathology endpoints for inflammatory bowel disease drug development.
The system automates cervical cytology with AI-powered sample preparation, imaging, and analysis...
The MMR IHC Panel pharmDx helps identify patients eligible for immunotherapy treatment with Bristol Myers Squibb's Opdivo alone or in combination with Yervoy.
Evident has launched the IXplore IX85 SpinXL and SpinSR, two advanced spinning disk confocal microscopes that enhance live-cell imaging.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.